Metoclopramide Oral liquid 5 mg/5 mL (p)

Metoclopramide Oral Liquid 5 mg/5 mL


Description

Metoclopramide Oral Liquid 5 mg/5 mL (often labeled ‘P’ for paediatric use, or implying a liquid formulation) is a clear to yellowish oral solution containing Metoclopramide Hydrochloride. This concentration means that every 5 milliliters of the liquid contains 5 milligrams of metoclopramide. It acts as an antiemetic (to prevent or treat nausea and vomiting) and a prokinetic agent (to speed up gastric emptying). It works by blocking dopamine receptors in the brain and enhancing the movement of the upper digestive tract. The liquid form allows for flexible and precise dosing, particularly useful for children or patients who have difficulty swallowing tablets.

Advantages

  • Flexible Dosing: The liquid formulation allows for accurate and easy dose adjustments, especially important for pediatric patients where dosing is often weight-based.
  • Ease of Administration: Ideal for children, elderly patients, or individuals who struggle to swallow pills.
  • Effective Antiemetic: Potently prevents and treats various types of nausea and vomiting.
  • Prokinetic Action: Accelerates gastric emptying, relieving symptoms like bloating and fullness and aiding in conditions like diabetic gastroparesis.
  • Rapid Absorption: As a liquid, it can be absorbed relatively quickly from the gastrointestinal tract.

Uses

Metoclopramide Oral Liquid 5 mg/5 mL is commonly used for:

  • Nausea and Vomiting: Prevention and treatment of nausea and vomiting caused by various factors, including chemotherapy, radiation therapy, post-operative states, and migraines.
  • Diabetic Gastroparesis: To relieve symptoms of delayed stomach emptying in diabetic patients (e.g., nausea, vomiting, bloating, fullness).
  • Gastroesophageal Reflux Disease (GERD): Short-term treatment of symptomatic GERD in patients who do not respond to conventional therapies.
  • Prevention of Delayed Chemotherapy-Induced Nausea and Vomiting (CINV): Used as a second-line option in children aged 1-18 years.
  • Facilitating Diagnostic Procedures: To speed up the passage of a tube into the small bowel for diagnostic purposes.

Nature

Metoclopramide is a dopamine D2 receptor antagonist. Its primary mechanisms of action are:

  1. Antiemetic Effect: It blocks dopamine D2 receptors in the chemoreceptor trigger zone (CTZ) in the brain, an area that triggers vomiting. This action prevents and relieves nausea and vomiting.
  2. Prokinetic Effect: It enhances the release of acetylcholine in the gastrointestinal tract. Acetylcholine promotes increased tone and amplitude of gastric contractions, relaxes the pyloric sphincter, and increases peristalsis in the small intestine. This results in accelerated gastric emptying and intestinal transit. It also increases the resting pressure of the lower esophageal sphincter, reducing reflux.

By influencing both central and peripheral dopamine receptors, Metoclopramide effectively manages symptoms related to impaired gastrointestinal motility and the vomiting reflex.

Storage

  • Room Temperature: Store Metoclopramide Oral Liquid 5 mg/5 mL at controlled room temperature, typically between 20°C to 25°C (68°F to 77°F).
  • Protect from Light: Keep the bottle in its original packaging to protect it from light, which can degrade the product.
  • Protect from Freezing: Do not freeze the liquid, as this can alter its consistency and effectiveness.
  • Keep Out of Reach of Children: Store the medication in a secure place, well out of the sight and reach of children and pets. Always use the provided measuring syringe or spoon to ensure accurate dosing and prevent accidental overdose.
  • Check Expiry Date: Do not use the medication after the expiry date.

Precautions

  • Risk of Tardive Dyskinesia (TD): A serious, potentially irreversible movement disorder. Risk increases with higher doses and longer treatment duration. Limit treatment duration, generally not exceeding 12 weeks, especially in adults.
  • Extrapyramidal Symptoms (EPS): Involuntary movements like muscle spasms, restlessness (akathisia), or tremors can occur, particularly in children and young adults.
  • Neuroleptic Malignant Syndrome (NMS): A rare but severe reaction characterized by high fever, muscle stiffness, confusion, and changes in heart rate/blood pressure.
  • Contraindicated if you have:
    • Pheochromocytoma (adrenal gland tumor) due to risk of hypertensive crisis.
    • Gastrointestinal hemorrhage, obstruction, or perforation.
    • Epilepsy or other seizure disorders.
    • History of Tardive Dyskinesia or other movement problems from similar drugs.
  • Caution in: Patients with kidney or liver problems (dose adjustment may be needed), heart conditions, Parkinson’s disease (can worsen symptoms), and depression (may worsen mood).
  • Drowsiness: May cause drowsiness. Avoid driving or operating machinery until effects are known.
  • Alcohol: Avoid alcohol, as it can increase side effects.
  • Children: Use with extreme caution in children, especially infants, due to increased risk of EPS. Often restricted to second-line use for specific conditions in pediatric patients.
  • Drug Interactions: Inform your doctor about all medications, especially other dopamine-blocking drugs, anticholinergics, or CNS depressants.

Leave a Comment

Your email address will not be published. Required fields are marked *

Call Now Button